Assaf Moore
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Prostate Cancer Diagnosis and Treatment 8
- Medical Imaging and Pathology Studies 3
-
- Head and Neck Cancer Studies 4
- Co-authors
- Michal Sarfaty (15 shared papers)Noa Gordon (13 shared papers)Daniel A. Goldstein (10 shared papers)Hadar Goldvaser (11 shared papers)Tzippy Shochat (6 shared papers)Eli Rosenbaum (4 shared papers)Victoria Neiman (4 shared papers)Rinat Yerushalmi (6 shared papers)
- Journals
- Frontiers in Oncology (5 papers)Head & Neck (3 papers)Cancer Medicine (3 papers)Journal of Cancer (2 papers)European Urology Oncology (2 papers)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Assaf Moore
53 papers receiving 760 citations
Peers
Comparison fields: 5 of 62
- Oncology 256
- Hepatology 59
- Pulmonary and Respiratory Medicine 233
- Cancer Research 96
- Otorhinolaryngology 25
Countries citing papers authored by Assaf Moore
This map shows the geographic impact of Assaf Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assaf Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assaf Moore more than expected).
Fields of papers citing papers by Assaf Moore
This network shows the impact of papers produced by Assaf Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assaf Moore. The network helps show where Assaf Moore may publish in the future.
Co-authors
The 25 scholars most cited alongside Assaf Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 113 | |
| 2 | 2017 | 60 | |
| 3 | 2018 | 59 | |
| 4 | 2017 | 57 | |
| 5 | 2020 | 43 | |
| 6 | 2020 | 31 | |
| 7 | 2019 | 31 | |
| 8 | 2016 | 29 | |
| 9 | 2019 | 28 | |
| 10 | 1998 | 27 | |
| 11 | 2021 | 27 | |
| 12 | 2020 | 27 | |
| 13 | 2020 | 25 | |
| 14 | 2020 | 16 | |
| 15 | 2022 | 16 | |
| 16 | 2022 | 16 | |
| 17 | 2021 | 15 | |
| 18 | 2017 | 14 | |
| 19 | 2023 | 13 | |
| 20 | 2021 | 11 |
About Assaf Moore
Assaf Moore is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology, Oncology, Radiation and Surgery, having authored 55 papers that have together received 775 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (8 papers), Head and Neck Cancer Studies (4 papers), Advanced Radiotherapy Techniques (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Economic and Financial Impacts of Cancer (3 papers), Medical Imaging and Pathology Studies (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Radiation Dose and Imaging (2 papers). The work is most often cited by research in Oncology (256 citations), Hepatology (59 citations), Pulmonary and Respiratory Medicine (233 citations), Cancer Research (96 citations) and Otorhinolaryngology (25 citations). Assaf Moore has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Michal Sarfaty, Noa Gordon, Daniel A. Goldstein, Hadar Goldvaser, Tzippy Shochat, Eli Rosenbaum, Victoria Neiman, Rinat Yerushalmi, Salomon Marcello Stemmer and Moshe Leshno. Their work appears in journals such as Frontiers in Oncology, Head & Neck, Cancer Medicine, Journal of Cancer and European Urology Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.